---
schema_version: "secwatch.filing_event.v1"
accession: "0001650664-25-000031"
form_type: "8-K"
ticker: "EDIT"
cik: "0001650664"
company_name: "Editas Medicine, Inc."
filed_at: "2025-03-20T23:59:59+00:00"
generated_at: "2026-05-24T10:16:41.134518+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Editas Medicine CFO resigns; Amy Parison appointed as CFO

## Summary
- Erick Lucera resigns as EVP, CFO effective March 28, 2025.
- Amy Parison, previously SVP Finance, appointed SVP, CFO and Treasurer effective March 28, 2025.
- Parison receives $415k base salary, 40% target bonus, and option for 34,672 shares vesting monthly over 4 years.
- Parison joined Editas in Aug 2022 as VP Finance, Corporate Controller, promoted to SVP Finance Jan 2025.
- No arrangement or understanding behind Parison's selection; no reportable transactions.

## SEC filing metadata
- accession: 0001650664-25-000031
- form_type: 8-K
- ticker: EDIT
- cik: 0001650664
- company_name: Editas Medicine, Inc.
- filed_at: 2025-03-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/0001650664-25-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/edit-20250318.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001650664-25-000031
- JSON: https://secwatch.observer/filing/0001650664-25-000031.json
- Plain text: https://secwatch.observer/filing/0001650664-25-000031.txt

## Key facts
- Executive change
  Erick Lucera departed as Executive Vice President, Chief Financial Officer at Editas Medicine, Inc..
  - Action: resigning
  - Role: Executive Vice President, Chief Financial Officer
  source text: On March 18, 2025, Erick Lucera, Executive Vice President, Chief Financial Officer of Editas Medicine, Inc. (the “Company”) informed the Company that he will be resigning from his position effective March 28, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/0001650664-25-000031-index.htm
- Executive change
  Amy Parison was appointed as Senior Vice President, Chief Financial Officer and Treasurer at Editas Medicine, Inc..
  - Action: appointed
  - Role: Senior Vice President, Chief Financial Officer and Treasurer
  source text: In connection with Mr. Lucera’s resignation, on March 19, 2025 the Company appointed Amy Parison, Senior Vice President, Finance as Senior Vice President, Chief Financial Officer and Treasurer of the Company, to be effective as of the close of business on March 28, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000165066425000031/0001650664-25-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.